Elkfork Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $411K | Sell |
11,220
-102
| -0.9% | -$3.74K | 0.01% | 644 |
|
|
2019
Q2 | $527K | Sell |
11,322
-2,958
| -21% | -$138K | 0.01% | 564 |
|
|
2019
Q1 | $573K | Buy |
14,280
+442
| +3% | +$17.7K | 0.01% | 524 |
|
|
2018
Q4 | $636K | Sell |
13,838
-2,822
| -17% | -$130K | 0.02% | 456 |
|
|
2018
Q3 | $739K | Buy |
16,660
+14,450
| +654% | +$641K | 0.02% | 466 |
|
|
2018
Q2 | $87K | Sell |
2,210
-19,244
| -90% | -$758K | ﹤0.01% | 944 |
|
|
2018
Q1 | $1.55M | Buy |
21,454
+16,252
| +312% | +$1.18M | 0.04% | 262 |
|
|
2017
Q4 | $342K | Sell |
5,202
-3,774
| -42% | -$248K | 0.01% | 647 |
|
|
2017
Q3 | $450K | Sell |
8,976
-1,088
| -11% | -$54.5K | 0.01% | 514 |
|
|
2017
Q2 | $466K | Sell |
10,064
-3,400
| -25% | -$157K | 0.01% | 513 |
|
|
2017
Q1 | $475K | Hold |
13,464
| – | – | 0.01% | 468 |
|
|
2016
Q4 | $169K | Buy |
+13,464
| New | +$169K | 0.01% | 604 |
|